Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Citius Pharmaceuticals, Inc. (CTXR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/22/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
| 12/15/2021 |
10-K
| Annual Report for the period ended September 30, 2021 |
| 12/16/2020 |
10-K
| Annual Report for the period ended September 30, 2020 |
| 12/16/2019 |
10-K
| Annual Report for the period ended September 30, 2019 |
| 12/11/2018 |
10-K
| Annual Report for the period ended September 30, 2018 |
| 12/13/2017 |
10-K
| Annual Report for the period ended September 30, 2017 |
| 12/23/2016 |
10-K
| Annual Report for the period ended September 30, 2016 |
| 12/14/2015 |
10-K
| Annual Report for the period ended September 30, 2015 |
| 12/29/2014 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] |
| 02/06/2014 |
10-K
| Annual Report for the period ended September 30, 2013 |
| 01/15/2013 |
10-K
| Annual Report for the period ended September 30, 2012 |
| 01/13/2012 |
10-K
| Annual Report for the period ended September 30, 2011 |
|
|